Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Orchestra BioMed Holdings Inc | OBIO | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
6,91 | 6,86 | 8,00 | 7,93 | 6,86 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
11.6.2024 | 14:01 | EDGAR2 | Form 8-K - Current report |
03.6.2024 | 22:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
28.5.2024 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
24.5.2024 | 22:16 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
13.5.2024 | 22:38 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10.5.2024 | 23:25 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10.5.2024 | 23:24 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10.5.2024 | 23:23 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10.5.2024 | 23:18 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
09.5.2024 | 23:04 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
19.9.2023 | 16:19 | DJN | Orchestra BioMed Shares Jump on FDA Nod for BackBeat Study |
19.9.2023 | 14:24 | DJN | Orchestra BioMed Gets FDA Nod for BackBeat Study |